Industry / Bulgaria
BMI Maintains Forecast Of Strong Growth In Bulgaria
May 2006 | Industry ForecastBMI is maintaining its forecast of strong growth for the Bulgarian pharmaceutical market despite the release of conflicting data from the Bulgarian Drug Agency (BDA) and IMS
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
